Lice Treatment Market is expected to reach USD 156.44 million by 2029

In recent years, the lice treatment market is anticipated to grow rapidly during the forecast period. According to a UN survey released in 2019, the number of children under the age of 14 is anticipated to surpass 2.02 billion in 2019 and reach 2.06 billion by 2050. Because of the large number of people who are susceptible to lice infestation, the market is expected to develop. Lice is a parasite that feeds on human blood and thrives primarily on the head or public areas. Most lice treatments must be applied twice, seven to ten days apart, and nits must be removed by combing damp hair with a fine-toothed comb.

Data Bridge Market Research analyses that the lice treatment market was valued at USD 93.47 million in 2021 and is expected to reach USD 156.44 million by 2029, registering a CAGR of 6.65% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Lice are wingless, blood-sucking insects that feed on the blood of humans and live on their heads or scalps. When lice suck blood from people, they inject saliva. Blood coagulation is prevented by injecting saliva. Pruritus is a disease caused by lice saliva entering the human circulatory system. The lice's saliva may trigger severe allergic reactions in some people, and the lice's sharp claws can cause itching and pain by moving through hair strands. Lice treatments (called pediculicides) are accessible without a prescription or over the counter. Shampoos, lotions, and cream rinses are among them.

Read More:
https://www.databridgemarketresearch.com/reports/global-lice-treatment-market

Recent Development

In October 2020, U.S. Food and Drug Administration (FDA) had announced the approval of a lotion used in the treatment of head lice for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch. The prescription drug manufacturer usually initiates the changeover from prescription to over-the-counter. The evidence presented must demonstrate that the drug is safe and effective when used as instructed in the proposed labelling for it to be switched from prescription to nonprescription status. According to the company, consumers must be able to grasp how to use the drug safely and efficiently without the assistance of a healthcare expert.

Some of the major players operating in the lice treatment market are:

F. Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (US)
Teva Pharmaceutical Industries Ltd.(Israel)
Sanofi (France), Pfizer Inc. (US)
GlaxoSmithKline plc (UK)
Novartis AG (Switzerland)
AstraZeneca (UK)
Johnson & Johnson (US)
Bayer AG (Germany)
Sun Pharmaceutical Industries Ltd. (India)
Eli Lilly and Company (US)
Edenbridge Pharmaceuticals, LLC (US)
ParaPRO LLC (US)
Encube Ethicals (India)
GALDERMA (Switzerland)
Alliance Pharmaceuticals (UK)
Foamix Pharmaceuticals Ltd (US)
Arbor Pharmaceuticals (US)
Dr. Reddy's Laboratories Ltd. (India)
Perrigo Company plc (Ireland)

More Links:

https://dbmrbuisness.blogspot.com/2023/07/global-bone-resorption-inhibitors.html

https://dbmrbuisness.blogspot.com/2023/07/global-antidepressants-market-industry.html

https://dbmrbuisness.blogspot.com/2023/07/global-non-cardioselective-beta.html

https://dbmrbuisness.blogspot.com/2023/07/global-exanthema-market-industry-trends.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.